-
公开(公告)号:US20240041957A1
公开(公告)日:2024-02-08
申请号:US18255444
申请日:2021-12-03
申请人: UCL Business LTD
CPC分类号: A61K35/76 , C12N15/86 , C12N2740/16043 , C12N2830/48 , C12N2740/16032
摘要: There is provided a retroviral RNA vector comprising a 5′ cap, a transgene, a 3′ long terminal repeat (LTR) and an RNA packaging sequence, wherein translation of the transgene is initiated at the 5′ end of the transgene in a cap-dependent manner, and wherein the 3′ LTR and the RNA packaging sequence are located 3′ of the transgene. Also provided is a nucleotide sequence encoding a vector genome. In addition, there is provided a host cell, a virion and a pharmaceutical composition comprising the vector or nucleotide sequence, and the use of the vector in delivering a transgene to a cell or subject.
-
公开(公告)号:US20130089525A1
公开(公告)日:2013-04-11
申请号:US13267977
申请日:2011-10-07
CPC分类号: A61K38/162 , A61K38/08 , A61K45/06 , A61K47/60 , C07K7/06 , C12N7/00 , C12N2740/16032 , Y02A50/401 , Y02A50/471 , Y02A50/473 , Y02A50/475 , Y02A50/478 , Y02A50/481
摘要: The present application discloses a method for treating microbial infection using an antimicrobial composition comprises antimicrobial peptide which contains at least one VGFPV motif.
摘要翻译: 本申请公开了一种使用抗微生物组合物治疗微生物感染的方法,其包含含有至少一种VGFPV基序的抗微生物肽。
-
公开(公告)号:US20190083523A1
公开(公告)日:2019-03-21
申请号:US16132247
申请日:2018-09-14
发明人: Charles David Pauza , Haishan Li , Tyler Lahusen , Mei-Ling Liou
IPC分类号: A61K31/7105 , A61K31/675 , A61P35/02 , A61K47/69 , A61K47/68
CPC分类号: A61K31/7105 , A61K31/675 , A61K47/6807 , A61K47/6901 , A61K2300/00 , A61P35/02 , C12N15/1137 , C12N15/86 , C12N2310/14 , C12N2310/531 , C12N2330/51 , C12N2740/16032 , C12N2740/16043 , C12N2740/16045 , C12N2750/14143 , C12N2810/6072 , C12Y205/0101
摘要: The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
-
公开(公告)号:US20180057594A1
公开(公告)日:2018-03-01
申请号:US15720696
申请日:2017-09-29
申请人: ONCORUS, INC.
发明人: Luke EVNIN
IPC分类号: C07K16/28 , C12N7/00 , C07K16/30 , C07K14/705 , C07K14/725 , C12N9/64 , A61K35/768
CPC分类号: C07K16/2818 , A61K35/76 , A61K35/768 , A61K2039/507 , C07K14/4703 , C07K14/522 , C07K14/5434 , C07K14/5443 , C07K14/70503 , C07K14/7051 , C07K14/70532 , C07K14/70596 , C07K16/2803 , C07K16/2809 , C07K16/2827 , C07K16/3092 , C07K2317/31 , C07K2317/76 , C07K2319/00 , C07K2319/03 , C07K2319/30 , C12N7/00 , C12N9/6491 , C12N15/86 , C12N2710/16633 , C12N2710/16641 , C12N2740/16032 , C12N2740/16043 , C12N2760/20232 , C12N2760/20243 , Y02A50/466
摘要: Described herein are pseudotyped oncolytic viruses comprising nucleic acids encoding an engager molecule. In some embodiments, the pseudotyped oncolytic viruses comprises nucleic acids encoding an engager molecule and one or more therapeutic molecules. Pharmaceutical compositions containing the pseudotyped oncolytic virus and methods of treating cancer using the pseudotyped oncolytic viruses are further provided herein.
-
公开(公告)号:US20160311891A1
公开(公告)日:2016-10-27
申请号:US15103970
申请日:2014-12-13
CPC分类号: C07K16/1081 , A61K48/005 , A61K2039/505 , A61K2039/53 , A61K2039/54 , A61M2037/0007 , C07K16/10 , C07K16/1063 , C07K16/32 , C07K2317/10 , C07K2317/51 , C07K2317/522 , C07K2317/524 , C07K2317/526 , C07K2317/53 , C07K2317/55 , C07K2317/56 , C07K2317/60 , C07K2317/76 , C07K2319/00 , C12N7/00 , C12N2740/16032 , C12N2740/16111 , C12N2740/16122 , C12N2770/24111 , C12N2770/24122 , C12N2770/24133 , C12N2770/24171 , C12N2770/36111 , C12N2770/36122 , C12N2770/36133 , C12N2770/36171 , Y02A50/383 , Y02A50/386
摘要: Disclosed herein is a composition including a recombinant nucleic acid sequence that encodes an antibody. Also disclosed herein is a method of generating a synthetic antibody in a subject by administering the composition to the subject. The disclosure also provides a method of preventing and/or treating disease in a subject using said composition and method of generation.
摘要翻译: 本文公开了包含编码抗体的重组核酸序列的组合物。 本文还公开了通过将所述组合物施用于受试者来在受试者中产生合成抗体的方法。 本公开还提供了使用所述组合物和产生方法预防和/或治疗受试者的疾病的方法。
-
公开(公告)号:US20140030792A1
公开(公告)日:2014-01-30
申请号:US13940122
申请日:2013-07-11
IPC分类号: C12N7/00
CPC分类号: C12N7/00 , C12N7/045 , C12N15/1131 , C12N2310/141 , C12N2740/16021 , C12N2740/16032 , C12N2740/16043 , C12N2740/16062
摘要: This invention provides therapeutic viruses (TV) and methods to inhibit the propagation of a target virus. TVs can be rendered noninfectious by inactivating mutations, but also include sequences providing miRNA to inactivate essential mRNAs of the target virus. Methods can include provision of the TV and contact with a host cell harboring the target virus. The target virus providing the essential enzymes necessary to the replication of the TV and the TV disabling the target virus with the miRNA.
摘要翻译: 本发明提供了治疗病毒(TV)和抑制靶病毒繁殖的方法。 电视可以通过灭活突变而变得非传染性,但也包括提供miRNA来灭活靶病毒的基本mRNA的序列。 方法可以包括提供电视并与携带目标病毒的宿主细胞接触。 提供复制电视和电视所需的必需酶的目标病毒能够使用miRNA抑制靶病毒。
-
公开(公告)号:US12083159B2
公开(公告)日:2024-09-10
申请号:US16811754
申请日:2020-03-06
IPC分类号: A61K38/16 , A61K38/08 , A61K45/06 , A61K47/60 , A61K47/64 , C07K7/06 , C07K14/005 , C12N7/00
CPC分类号: A61K38/162 , A61K38/08 , A61K45/06 , A61K47/60 , A61K47/6455 , C07K7/06 , C07K14/005 , C12N7/00 , C07K2319/10 , C12N2740/16032 , C12N2740/16322 , Y02A50/30
摘要: Compositions and methods for reducing the growth of and/or preventing the formation of a microbial biofilm are disclosed. The composition comprises an antimicrobial SMR peptide comprising an HIV-1 SMRwt peptide and a cell penetrating peptide (CPP) domain. In some embodiments, the composition further comprises one or more other antimicrobial peptides (AMPs), antibiotics, matrix-inhibiting compounds, matrix-disaggregating compounds, quorum sensing inhibitors, or a combination thereof. In other embodiments, the compositions are used for impregnating or coating an article and/or material surface with the composition to render it less prone to microbial infections.
-
8.
公开(公告)号:US20230399627A1
公开(公告)日:2023-12-14
申请号:US18251264
申请日:2021-11-02
发明人: Benshang LI , Tianyi WANG , Xinyu WAN , Xiaomin YANG
CPC分类号: C12N5/10 , C12N15/79 , C12N15/62 , C12N2740/16032
摘要: Provided are a vector genetically engineered with a chimeric antigen receptor and against two or more targets for combined treatment of disease such as human tumors, a related immune cell and application thereof. The vector genetically engineered with a chimeric antigen receptor and the related immune cell have enhanced ability to kill target cells.
-
公开(公告)号:US20170173124A1
公开(公告)日:2017-06-22
申请号:US15383030
申请日:2016-12-19
发明人: Adrian THRASHER , Donald KOHN , Bobby GASPAR
CPC分类号: A61K38/50 , A61K35/28 , A61K48/0008 , A61K48/0066 , C07K14/4705 , C12N7/00 , C12N9/78 , C12N15/86 , C12N2740/16032 , C12N2740/16043 , C12N2740/16062 , C12N2740/16071 , C12Y305/04004
摘要: The present invention relates to the prevention and/or treatment of ADA-SCID, in a patient.
-
公开(公告)号:US08669226B2
公开(公告)日:2014-03-11
申请号:US13267977
申请日:2011-10-07
IPC分类号: A61K38/10 , A61K38/04 , A61K38/00 , A61K38/17 , C07K7/00 , C07K7/06 , C07K7/08 , A61P31/04 , A61P31/00 , A01N63/00
CPC分类号: A61K38/162 , A61K38/08 , A61K45/06 , A61K47/60 , C07K7/06 , C12N7/00 , C12N2740/16032 , Y02A50/401 , Y02A50/471 , Y02A50/473 , Y02A50/475 , Y02A50/478 , Y02A50/481
摘要: The present application discloses a method for treating microbial infection using an antimicrobial composition comprises antimicrobial peptide which contains at least one VGFPV motif.
摘要翻译: 本申请公开了一种使用抗微生物组合物治疗微生物感染的方法,其包含含有至少一种VGFPV基序的抗微生物肽。
-
-
-
-
-
-
-
-
-